Lv21
160 积分 2023-04-20 加入
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept
2小时前
待确认
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study
3小时前
已完结
A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 Diabetes
4小时前
求助中
A 26-Week Randomized Controlled Trial of Semaglutide Once Daily Versus Liraglutide and Placebo in Patients With Type 2 Diabetes Suboptimally Controlled on Diet and Exercise With or Without Metformin
4小时前
求助中
中国胃食管反流病诊疗规范
1个月前
已完结
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
2个月前
已完结
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
4个月前
已完结
GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
5个月前
已完结
皖公网安备34019202002308
